Related Experiment Video
Updated: Mar 28, 2026

04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
11.0K
Patient-specific meta-analysis for risk assessment using multivariate proportional hazards regression
1Department of Biostatistics, Genomic Health, Inc., 301 Penobscot Drive, Redwood City, CA 94063, USA.
Journal of Applied Statistics
|December 15, 2015
Summary
This study introduces a novel meta-analysis method for predicting individual patient clinical event risk. It combines Cox regression data from multiple studies for more accurate risk assessment.
Area of Science:
- Biostatistics
- Clinical Epidemiology
- Health Outcomes Research
Background:
- Accurate prediction of future clinical events is crucial for personalized medicine.
- Existing methods often struggle to integrate data from multiple clinical trials or cohort studies effectively.
- Meta-analysis techniques offer a powerful framework for synthesizing evidence but require adaptation for individual patient risk prediction.
Purpose of the Study:
- To develop and validate a novel meta-analysis method for assessing individual patient risk of future clinical events.
- To enable the integration of data from diverse clinical trial and cohort studies.
- To provide a flexible framework applicable to various regression models.
Main Methods:
- Proposed a method combining patient-specific log cumulative hazard estimates across studies.
- Utilized Cox proportional hazards regression and meta-analysis techniques (fixed- and random-effects models).
- Employed weighting by the relative precision of estimates from each study.
Main Results:
- The method successfully combines information from multiple studies for risk prediction.
- Patient risk assessment can be performed using summary statistics derived from each study.
- Simulations and real-data applications demonstrated the method's validity and utility.
- The approach is generalizable to logistic regression and linear models.
Conclusions:
- The developed meta-analysis method provides a robust approach for individual patient risk prediction.
- This technique enhances the utility of existing clinical trial and cohort data for future event forecasting.
- The method offers a significant advancement in synthesizing multi-study data for clinical decision-making.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
704
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
704
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
529
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
529
Hazard Ratio
698
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
698
Hazard Rate
489
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
489
Cancer Survival Analysis
827
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
827
Relative Risk
2.5K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K

